MAPKs in the early steps of senescence implemEMTation
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Evidence is accumulating that the earliest stages of the DNA damage response can direct cells toward senescence instead of other cell fates. In particular, tightly regulated signaling through Mitogen-Activated Protein Kinases (MAPKs) in early senescence can lead to a sustained pro-survival program and suppress a pro-apoptotic program. Importantly, an epithelial-to-mesenchymal Transition (EMT)-like program appears essential for preventing apoptosis and favoring senescence following DNA damage. In this review, we discuss how MAPKs might influence EMT features to promote a senescent phenotype that increases cell survival at the detriment of tissue function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“consistent with enhanced paracrine signaling from increased numbers of senescent neighbors and with established features of epithelial aging.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [25]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A major challenge in the field has been to reliably identify senescent cells in tissues and organs.23,25,32–35”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 1×
“However, when senescent cells accumulate to aberrantly high levels, their normal homeostatic influence is disrupted, creating a pro-inflammatory state that impairs organ function, reduces regeneration, and fuels aging-associated decline and disease (Lopez-Otin et al., 2013; He and Sharpless, 2017).”
BackgroundEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876 · cited 6×
“Nonetheless, the EMT is a complex, cell type-dependent program that relies on multiple transcription factors, sometimes shared and sometimes exclusive to each cell context (Zavadil et al., 2004; Leroy and Mostov, 2007; Dhasarathy et al., 2011; Ganesan et al., 2016; Dongre and Weinberg, 2019; Sundararajan et al., 2019;…”
BackgroundInfluentialActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274 · cited 6×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“Senescence is a cellular response to different types of sublethal damage characterized by indefinite cell cycle arrest and the secretion of bioactive molecules (Childs et al., 2014; Gorgoulis et al., 2019).”
BackgroundWound Healing: A Cellular Perspective
Rodrigues, M., Kosaric, N., Bonham, C. A., & Gurtner, G. C. (2019) · Physiological Reviews · doi:10.1152/physrev.00067.2017 · Cited by 3,013 · cited 1×
“In fact, the dynamic change in the SASP is reminiscent of the overall process observed during wound healing (Rodrigues et al., 2019) and further supports the idea of senescent cells as vital elements of tissue remodeling after damage.”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 1×
“These programs reflect an evolutionary adaptation to damage that coordinates the responses to injury in multicellular organisms (van Deursen, 2014; Childs et al., 2015).”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 6×
“, 2021), and senescent cells express many of the receptors to which these extracellular ligands bind (Acosta et al., 2013; Rapisarda et al., 2017; Anerillas et al., 2022a; Anerillas et al., 2022b).”
BackgroundInfluentialAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045 · cited 1×
“In this regard, senescent cells serve as “sentinels” of the damage encountered, and they coordinate nearby and distant responses through the secreted factors acting in a paracrine and endocrine fashion to promote organism homeostasis (Munoz-Espin et al., 2013; Storer et al., 2013; Demaria et al., 2014).”
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
Massague, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,966
EMT, the cytoskeleton, and cancer cell invasion
Yilmaz, M., & Christofori, G. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9169-0 · Cited by 1,788 · cited 1×
“Furthermore, many of the molecules secreted by senescent cells, including cytokines, growth factors, and ECM proteins, are known EMT triggers (Krtolica et al., 2001; Parrinello et al., 2005; Yilmaz and Christofori, 2009; Coppe et al., 2010; Acosta et al., 2013; Lamouille et al., 2014; Hoare et al., 2016; Cherubini et…”
BackgroundSenescence in Health and Disease
He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766 · cited 2×
“However, when senescent cells accumulate to aberrantly high levels, their normal homeostatic influence is disrupted, creating a pro-inflammatory state that impairs organ function, reduces regeneration, and fuels aging-associated decline and disease (Lopez-Otin et al., 2013; He and Sharpless, 2017).”
BackgroundKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730 · cited 1×
“Furthermore, many of the molecules secreted by senescent cells, including cytokines, growth factors, and ECM proteins, are known EMT triggers (Krtolica et al., 2001; Parrinello et al., 2005; Yilmaz and Christofori, 2009; Coppe et al., 2010; Acosta et al., 2013; Lamouille et al., 2014; Hoare et al., 2016; Cherubini et…”
BackgroundCellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 3×
“The fact that senescent cells produce pro-EMT proteins suggests that they may contribute to fibrosis in detrimental scenarios (Schafer et al., 2017; Levi et al., 2020; Ritschka et al., 2020; Anerillas et al., 2022a).”
BackgroundBaar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454 · cited 2×
“TGF-β and p53 induce p21 expression (Dupont et al., 2004; Elston and Inman, 2012; Baar et al., 2017), and may jointly support the implementation of an EMT-like program in senescent cells (Cordenonsi et al.”
BackgroundProgrammed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428 · cited 3×
“Downstream of membrane receptors, many signaling pathways related to both EMT and senescence are activated along with the MAPKs; these signaling modules include WNT-β-Catenin, NOTCH, SMADs, AKT-mTOR, and STATs (Acosta et al., 2013; Munoz-Espin et al., 2013; Herranz et al., 2015; Laberge et al., 2015; Hoare et al., 201…”
BackgroundThe Snail genes as inducers of cell movement and survival: implications in development and cancer
Barrallo-Gimeno, A., & Nieto, M. A. (2005) · Development · doi:10.1242/dev.01907 · Cited by 1,394 · cited 1×
“At the same time, the EMT program could also favor viability by promoting the increase of pro-survival proteins, as seen in cancer (Barrallo-Gimeno and Nieto, 2005; Lamouille et al., 2014; Gupta and Maitra, 2016), although these possibilities need to be investigated in senescent cells.”
BackgroundSenescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 3×
“In this regard, senescent cells serve as “sentinels” of the damage encountered, and they coordinate nearby and distant responses through the secreted factors acting in a paracrine and endocrine fashion to promote organism homeostasis (Munoz-Espin et al., 2013; Storer et al., 2013; Demaria et al., 2014).”
BackgroundLaberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · cited 1×
“Downstream of membrane receptors, many signaling pathways related to both EMT and senescence are activated along with the MAPKs; these signaling modules include WNT-β-Catenin, NOTCH, SMADs, AKT-mTOR, and STATs (Acosta et al., 2013; Munoz-Espin et al., 2013; Herranz et al., 2015; Laberge et al., 2015; Hoare et al., 201…”
BackgroundCellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134 · cited 2×
“In this regard, senescent cells have been linked to many age-related diseases including neurodegeneration, diabetes, obesity, sarcopenia, and cardiovascular disorders (Chaib et al., 2022).”
BackgroundThe multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129 · cited 2×
“Some level of restraint of p53 activity by EMT would enable cell viability while arresting proliferation, since p53 is essential for both senescence and apoptosis (Childs et al., 2014; Hafner et al., 2019).”
BackgroundFreund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“For example, a p53-mediated rise in the levels of the phosphatase WIP1 suppressed p38 activation during senescence (Freund et al., 2011), although WIP1 suppresses other MAPKs in different cell types (Goloudina et al.”
BackgroundDirected elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032 · cited 1×
“Several studies have shown that an efficient way to eliminate senescent cells is by forcing them into apoptosis, given that senescent cells manifest an underlying pro-apoptotic state elicited by the damage they have endured (Yosef et al., 2016; Baar et al., 2017; Anerillas et al., 2022b).”
BackgroundFeedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019 · cited 12×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialSignaling cross-talk between TGF-β/BMP and other pathways
Guo, X., & Wang, X.-F. (2009) · Cell Research · doi:10.1038/cr.2008.302 · Cited by 1,015 · cited 2×
“, 2004), or by tilting the balance between SMAD2/3 and SMAD1/5/9 (Guo and Wang, 2009; Zou et al., 2021) to affect cell outcomes.”
BackgroundCensus and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971 · cited 5×
“…p53 can inhibit MAPK activity (e.g., by inducing phosphatases like the dual-specificity phosphatases, DUSPs), but the specific MAPKs inhibited vary depending on the cell type, the stimulus, and the phosphatases expressed (Lu et al., 2007; Yu et al., 2007; Lokareddy et al., 2013; Fischer, 2017).”
BackgroundInfluentialSenescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915 · cited 3×
“Senescence is a cellular response to different types of sublethal damage characterized by indefinite cell cycle arrest and the secretion of bioactive molecules (Childs et al., 2014; Gorgoulis et al., 2019).”
BackgroundGenetic compensation: A phenomenon in search of mechanisms
El-Brolosy, M. A., & Stainier, D. Y. R. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006780 · Cited by 829 · cited 1×
“In short, the influence of p53 on MAPKs during early senescence is complex, depends on cell context, and is likely interdependent on other signaling events, as reported in other systems (Cargnello and Roux, 2011; El-Brolosy and Stainier, 2017).”
BackgroundmTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3225 · Cited by 788 · cited 1×
“Downstream of membrane receptors, many signaling pathways related to both EMT and senescence are activated along with the MAPKs; these signaling modules include WNT-β-Catenin, NOTCH, SMADs, AKT-mTOR, and STATs (Acosta et al., 2013; Munoz-Espin et al., 2013; Herranz et al., 2015; Laberge et al., 2015; Hoare et al., 201…”
BackgroundDynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761 · cited 1×
“Nonetheless, the EMT is a complex, cell type-dependent program that relies on multiple transcription factors, sometimes shared and sometimes exclusive to each cell context (Zavadil et al., 2004; Leroy and Mostov, 2007; Dhasarathy et al., 2011; Ganesan et al., 2016; Dongre and Weinberg, 2019; Sundararajan et al., 2019;…”
BackgroundIntegration of TGF‐β/Smad and Jagged1/Notch signalling in epithelial‐to‐mesenchymal transition
Zavadil, J., Cermak, L., Soto‐Nieves, N., & Böttinger, E. P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600069 · Cited by 746 · cited 1×
“Nonetheless, the EMT is a complex, cell type-dependent program that relies on multiple transcription factors, sometimes shared and sometimes exclusive to each cell context (Zavadil et al., 2004; Leroy and Mostov, 2007; Dhasarathy et al., 2011; Ganesan et al., 2016; Dongre and Weinberg, 2019; Sundararajan et al., 2019;…”
Backgroundp53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
Chang, C.-J., Chao, C.-H., Xia, W., Yang, J.-Y., Xiong, Y., Li, C.-W., Yu, W.-H., Rehman, S. K., Hsu, J. L., Lee, H.-H., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2173 · Cited by 745 · cited 1×
“, 2020) and TWIST1 and ZEB1 in cancer cells (Chang et al., 2011; Yang-Hartwich et al., 2019; Semenov et al., 2022).”
BackgroundTGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses
Yu, L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf366 · Cited by 721 · cited 12×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialThe senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.
Ritschka, B., Storer, M., Mas, A., Heinzmann, F., Ortells, M. C., Morton, J. P., Sansom, O. J., Zender, L., & Keyes, W. M. (2017) · Genes & Development · doi:10.1101/gad.290635.116 · Cited by 650 · cited 1×
“However, persistent SASP can trigger an exacerbated response that hampers tissue regeneration through uncontrolled inflammation, sometimes reducing the stemness of key cells (Ritschka et al., 2017).”
BackgroundParrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631 · cited 1×
“Furthermore, many of the molecules secreted by senescent cells, including cytokines, growth factors, and ECM proteins, are known EMT triggers (Krtolica et al., 2001; Parrinello et al., 2005; Yilmaz and Christofori, 2009; Coppe et al., 2010; Acosta et al., 2013; Lamouille et al., 2014; Hoare et al., 2016; Cherubini et…”
BackgroundTGF-β Family Signaling in the Control of Cell Proliferation and Survival
Zhang, Y., Alexander, P. B., & Wang, X.-F. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022145 · Cited by 626 · cited 1×
“As TGF-β can ensure viability or promote apoptosis depending on the cell status (Zhang et al., 2017), it will be critical to understand whether p53 somehow controls the production of proteins in the TGF-β family during cell fate decisions to alter the balance between senescence and apoptosis.”
BackgroundThe dynamic nature of senescence in cancer
Lee, S., & Schmitt, C. A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0249-2 · Cited by 588 · cited 1×
“The factors responsible for favoring a program of senescence over apoptosis following damage are not sufficiently known (Hoare et al., 2016; Lee and Schmitt, 2019; Anerillas et al., 2022b).”
BackgroundImpaired immune surveillance accelerates accumulation of senescent cells and aging
Ovadya, Y., Landsberger, T., Leins, H., Vadai, E., Gal, H., Biran, A., Yosef, R., Sagiv, A., Agrawal, A., Shapira, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07825-3 · Cited by 578 · cited 1×
“When this stage begins to decline, a more pro-inflammatory stage follows, during which cytokines and inflammatory mediators are robustly expressed, leading to enhanced immune surveillance and clearance of senescent cells (Tasdemir et al., 2016; Ovadya et al., 2018; Prata et al., 2018; Desdin-Mico et al., 2020).”
BackgroundT cells with dysfunctional mitochondria induce multimorbidity and premature senescence
Desdín-Micó, G., Soto-Heredero, G., Aranda, J. F., Oller, J., Carrasco, E., Gabandé-Rodríguez, E., Blanco, E. M., Alfranca, A., Cussó, L., Desco, M., et al. (2020) · Science · doi:10.1126/science.aax0860 · Cited by 572 · cited 1×
“When this stage begins to decline, a more pro-inflammatory stage follows, during which cytokines and inflammatory mediators are robustly expressed, leading to enhanced immune surveillance and clearance of senescent cells (Tasdemir et al., 2016; Ovadya et al., 2018; Prata et al., 2018; Desdin-Mico et al., 2020).”
BackgroundNOTCH1 mediates a switch between two distinct secretomes during senescence
Hoare, M., Ito, Y., Kang, T.-W., Weekes, M. P., Matheson, N. J., Patten, D. A., Shetty, S., Parry, A. J., Menon, S., Salama, R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3397 · Cited by 522
EMT as the ultimate survival mechanism of cancer cells
Tiwari, N., Gheldof, A., Tatari, M., & Christofori, G. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.013 · Cited by 512 · cited 1×
“The EMT is a developmental process through which epithelial cells lose their polarity and acquire mesenchymal characteristics to form new tissue structures and often to improve cell survival (Tiwari et al., 2012; Dongre and Weinberg, 2019).”
BackgroundSenescent cell clearance by the immune system: Emerging therapeutic opportunities
Prata, L. G. P. L., Ovsyannikova, I. G., Tchkonia, T., & Kirkland, J. L. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.003 · Cited by 497 · cited 1×
“When this stage begins to decline, a more pro-inflammatory stage follows, during which cytokines and inflammatory mediators are robustly expressed, leading to enhanced immune surveillance and clearance of senescent cells (Tasdemir et al., 2016; Ovadya et al., 2018; Prata et al., 2018; Desdin-Mico et al., 2020).”
BackgroundBRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance
Tasdemir, N., Banito, A., Roe, J.-S., Alonso-Curbelo, D., Camiolo, M., Tschaharganeh, D. F., Huang, C.-H., Aksoy, O., Bolden, J. E., Chen, C.-C., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0217 · Cited by 415 · cited 1×
“When this stage begins to decline, a more pro-inflammatory stage follows, during which cytokines and inflammatory mediators are robustly expressed, leading to enhanced immune surveillance and clearance of senescent cells (Tasdemir et al., 2016; Ovadya et al., 2018; Prata et al., 2018; Desdin-Mico et al., 2020).”
BackgroundLinks between Tumor Suppressors
Cordenonsi, M., Dupont, S., Maretto, S., Insinga, A., Imbriano, C., & Piccolo, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00308-8 · Cited by 382 · cited 1×
“, 2017), and may jointly support the implementation of an EMT-like program in senescent cells (Cordenonsi et al., 2003; Teodoro et al., 2006; Sasai et al., 2008; Overstreet et al., 2014; Kawarada et al., 2016).”
BackgroundSugiura, R., Satoh, R., & Takasaki, T. (2021) · Cells · doi:10.3390/cells10102509 · Cited by 369
Gadd45 in Stress Signaling, Cell Cycle Control, and Apoptosis
Salvador, J. M., Brown-Clay, J. D., & Fornace, A. J. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-8289-5_1 · Cited by 308 · cited 2×
“At the same time, p53 also favors the activation of certain MAPKs by transcriptionally inducing the expression of EPHA2 (Macrae et al., 2005) or GADD45A (Salvador et al., 2013), which trigger the activation of ERK1/2 and p38, respectively.”
Backgroundp53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, H. S., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 308 · cited 1×
“p53 can affect other EMT-related pathways in different and complex ways; for example, the WNT-β-Catenin pathway is repressed by the p53-induced microRNA miR-34 (Kim et al., 2011), and similar to the effect on STAT3, p53 can both inhibit and be required for NOTCH expression in different cell contexts (Lefort et al.”
BackgroundLefort, K., Mandinova, A., Ostano, P., Kolev, V., Calpini, V., Kolfschoten, I., Devgan, V., Lieb, J., Raffoul, W., Hohl, D., et al. (2007) · Genes & Development · doi:10.1101/gad.1484707 · Cited by 305 · cited 1×
“, 2011), and similar to the effect on STAT3, p53 can both inhibit and be required for NOTCH expression in different cell contexts (Lefort et al., 2007).”
BackgroundCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 1×
“This antagonism is in keeping with the existence of a balance between competing signaling pathways in other aspects in senescence (Coppe et al., 2008; Hoare et al., 2016).”
Backgroundp21 produces a bioactive secretome that places stressed cells under immunosurveillance
Sturmlechner, I., Zhang, C., Sine, C. C., van Deursen, E.-J., Jeganathan, K. B., Hamada, N., Grasic, J., Friedman, D., Stutchman, J. T., Can, I., et al. (2021) · Science · doi:10.1126/science.abb3420 · Cited by 295 · cited 11×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialPang, M.-F., Georgoudaki, A.-M., Lambut, L., Johansson, J., Tabor, V, Hagikura, K., Jin, Y., Jansson, M., Alexander, J. S., Nelson, C. M., et al. (2016) · Oncogene · doi:10.1038/onc.2015.133 · Cited by 283 · cited 12×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialThe Wip1 Phosphatase Acts as a Gatekeeper in the p53-Mdm2 Autoregulatory Loop
Lu, X., Ma, O., Nguyen, T.-A., Jones, S. N., Oren, M., & Donehower, L. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.033 · Cited by 282 · cited 1×
“, by inducing phosphatases like the dual-specificity phosphatases, DUSPs), but the specific MAPKs inhibited vary depending on the cell type, the stimulus, and the phosphatases expressed (Lu et al., 2007; Yu et al., 2007; Lokareddy et al., 2013; Fischer, 2017).”
BackgroundA conditional feedback loop regulates Ras activity through EphA2
Macrae, M., Neve, R. M., Rodriguez-Viciana, P., Haqq, C., Yeh, J., Chen, C., Gray, J. W., & McCormick, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.005 · Cited by 260 · cited 2×
“At the same time, p53 also favors the activation of certain MAPKs by transcriptionally inducing the expression of EPHA2 (Macrae et al., 2005) or GADD45A (Salvador et al., 2013), which trigger the activation of ERK1/2 and p38, respectively.”
BackgroundZohn, I. E., Li, Y., Skolnik, E. Y., Anderson, K. V., Han, J., & Niswander, L. (2006) · Cell · doi:10.1016/j.cell.2006.03.048 · Cited by 248 · cited 12×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialHong, J., Zhou, J., Fu, J., He, T., Qin, J., Wang, L., Liao, L., & Xu, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2914 · Cited by 244 · cited 5×
“The same pathways in turn control the function of core EMT transcription factors SNAI1 (SNAIL), SNAI2 (SLUG), ZEBs Frontiers in Cell and Developmental Biology frontiersin.org02 (ZEB1 and ZEB2), TWISTs (TWIST1 and TWIST2), often activated to implement a pro-fibrotic extracellular matrix-remodeling state and inhibit apo…”
BackgroundInfluentialTransforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Shi, X., Young, C. D., Zhou, H., & Wang, X.-J. (2020) · Biomolecules · doi:10.3390/biom10121666 · Cited by 243
The Smad Dependent TGF-β and BMP Signaling Pathway in Bone Remodeling and Therapies
Zou, M.-L., Chen, Z.-H., Teng, Y.-Y., Liu, S.-Y., Jia, Y., Zhang, K.-W., Sun, Z.-L., Wu, J.-J., Yuan, Z.-D., Feng, Y., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.593310 · Cited by 242 · cited 2×
“, 2004), or by tilting the balance between SMAD2/3 and SMAD1/5/9 (Guo and Wang, 2009; Zou et al., 2021) to affect cell outcomes.”
BackgroundThe ECM path of senescence in aging: components and modifiers
Levi, N., Papismadov, N., Solomonov, I., Sagi, I., & Krizhanovsky, V. (2020) · The FEBS Journal · doi:10.1111/febs.15282 · Cited by 219 · cited 3×
“The fact that senescent cells produce pro-EMT proteins suggests that they may contribute to fibrosis in detrimental scenarios (Schafer et al., 2017; Levi et al., 2020; Ritschka et al., 2020; Anerillas et al., 2022a).”
BackgroundDynamics of TGF‐β/Smad signaling
Zi, Z., Chapnick, D. A., & Liu, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.063 · Cited by 205
Regulation of Dual-Specificity Phosphatase (DUSP) Ubiquitination and Protein Stability
Chen, H.-F., Chuang, H.-C., & Tan, T.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112668 · Cited by 205
p53-Mediated Inhibition of Angiogenesis Through Up-Regulation of a Collagen Prolyl Hydroxylase
Teodoro, J. G., Parker, A. E., Zhu, X., & Green, M. R. (2006) · Science · doi:10.1126/science.1126391 · Cited by 195 · cited 1×
“, 2017), and may jointly support the implementation of an EMT-like program in senescent cells (Cordenonsi et al., 2003; Teodoro et al., 2006; Sasai et al., 2008; Overstreet et al., 2014; Kawarada et al., 2016).”
BackgroundCorre, I., Paris, F., & Huot, J. (2017) · Oncotarget · doi:10.18632/oncotarget.18264 · Cited by 194 · cited 12×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialIntegrin Beta 3 Regulates Cellular Senescence by Activating the TGF-β Pathway
Rapisarda, V., Borghesan, M., Miguela, V., Encheva, V., Snijders, A. P., Lujambio, A., & O’Loghlen, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.012 · Cited by 190 · cited 3×
“, 2022b), and integrin signaling is important for promoting cellular senescence (Borghesan and O’Loghlen, 2017; Rapisarda et al., 2017; Jung et al., 2019; Shin et al., 2020).”
BackgroundSpatial and Temporal Control of Senescence
Ito, Y., Hoare, M., & Narita, M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.07.004 · Cited by 178 · cited 1×
“Senescence is implemented in at least two distinct phases in fibroblasts (Hoare et al., 2016; Ito et al., 2017).”
BackgroundDhasarathy, A., Phadke, D., Mav, D., Shah, R. R., & Wade, P. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026514 · Cited by 176 · cited 1×
“Nonetheless, the EMT is a complex, cell type-dependent program that relies on multiple transcription factors, sometimes shared and sometimes exclusive to each cell context (Zavadil et al., 2004; Leroy and Mostov, 2007; Dhasarathy et al., 2011; Ganesan et al., 2016; Dongre and Weinberg, 2019; Sundararajan et al., 2019;…”
BackgroundMechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition
Scott, L. E., Weinberg, S. H., & Lemmon, C. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00135 · Cited by 175 · cited 1×
“Furthermore, many of the molecules secreted by senescent cells, including cytokines, growth factors, and ECM proteins, are known EMT triggers (Krtolica et al., 2001; Parrinello et al., 2005; Yilmaz and Christofori, 2009; Coppe et al., 2010; Acosta et al., 2013; Lamouille et al., 2014; Hoare et al., 2016; Cherubini et…”
BackgroundErk5 Controls Slug Expression and Keratinocyte Activation during Wound Healing
Arnoux, V., Nassour, M., L'Helgoualc'h, A., Hipskind, R. A., & Savagner, P. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-1078 · Cited by 172 · cited 5×
“The evidence that ERK1/2 activate EMT core transcription factors like SNAIL, SLUG, TWIST, ZEB1, and ZEB2 (Weiss et al., 2012; Strippoli et al., 2015; Chiu et al., 2017; Sinh et al., 2017; Yuan et al., 2022) is mainly obtained from cancer cell studies.”
BackgroundInfluentialThe Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
Gregorio, J. D., Robuffo, I., Spalletta, S., Giambuzzi, G., Iuliis, V. D., Toniato, E., Martinotti, S., Conti, P., & Flati, V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607483 · Cited by 169
Regulation of senescence traits by MAPKs
Anerillas, C., Abdelmohsen, K., & Gorospe, M. (2020) · GeroScience · doi:10.1007/s11357-020-00183-3 · Cited by 166 · cited 7×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialSelf-citationKandhaya-Pillai, R., Miro-Mur, F., Alijotas-Reig, J., Tchkonia, T., Kirkland, J. L., & Schwartz, S. (2017) · Aging · doi:10.18632/aging.101328 · Cited by 165 · cited 1×
“Downstream of membrane receptors, many signaling pathways related to both EMT and senescence are activated along with the MAPKs; these signaling modules include WNT-β-Catenin, NOTCH, SMADs, AKT-mTOR, and STATs (Acosta et al., 2013; Munoz-Espin et al., 2013; Herranz et al., 2015; Laberge et al., 2015; Hoare et al., 201…”
BackgroundGenome‐wide cooperation of EMT transcription factor ZEB 1 with YAP and AP ‐1 in breast cancer
Feldker, N., Ferrazzi, F., Schuhwerk, H., Widholz, S. A., Guenther, K., Frisch, I., Jakob, K., Kleemann, J., Riegel, D., Bönisch, U., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103209 · Cited by 165 · cited 1×
“For instance, JNK activates the transcription factor AP-1, which can promote the expression of genes associated with EMT, such as SNAIL, SLUG, and TWISTs in both cancer and normal cells (Li et al., 2010; An et al., 2013; Feldker et al., 2020).”
BackgroundLiu, L., Cavanaugh, J. E., Wang, Y., Sakagami, H., Mao, Z., & Xia, Z. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332804100 · Cited by 161
Olea‐Flores, M., Zuñiga‐Eulogio, M. D., Catalán, M. A. M., Rodríguez-Ruiz, H. A., Castañeda-Saucedo, E., Ortuño‐Pineda, C., Padilla‐Benavides, T., & Navarro‐Tito, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122885 · Cited by 161 · cited 1×
“Importantly, the activity of ERK1/2 increases via ECM receptors and ECM ligands (Sheng et al., 2017; Ohkuro et al., 2018; Olea-Flores et al., 2019), and thus ERK1/2 activity could represent a key signaling node to adjust cell outcome to ECM status (Anerillas et al.”
BackgroundLeroy, P., & Mostov, K. E. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-09-0823 · Cited by 159 · cited 1×
“Nonetheless, the EMT is a complex, cell type-dependent program that relies on multiple transcription factors, sometimes shared and sometimes exclusive to each cell context (Zavadil et al., 2004; Leroy and Mostov, 2007; Dhasarathy et al., 2011; Ganesan et al., 2016; Dongre and Weinberg, 2019; Sundararajan et al., 2019;…”
BackgroundSheng, W., Chen, C., Dong, M., Wang, G., Zhou, J., He, S., Li, Y., Zhang, J., & Ding, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.547 · Cited by 157 · cited 1×
“Importantly, the activity of ERK1/2 increases via ECM receptors and ECM ligands (Sheng et al., 2017; Ohkuro et al., 2018; Olea-Flores et al., 2019), and thus ERK1/2 activity could represent a key signaling node to adjust cell outcome to ECM status (Anerillas et al.”
BackgroundWeiss, M. B., Abel, E. V., Mayberry, M. M., Basile, K. J., Berger, A. C., & Aplin, A. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1033 · Cited by 156 · cited 4×
“The evidence that ERK1/2 activate EMT core transcription factors like SNAIL, SLUG, TWIST, ZEB1, and ZEB2 (Weiss et al., 2012; Strippoli et al., 2015; Chiu et al., 2017; Sinh et al., 2017; Yuan et al., 2022) is mainly obtained from cancer cell studies.”
BackgroundInfluentialTGF-Beta Induced Erk Phosphorylation of Smad Linker Region Regulates Smad Signaling
Hough, C., Radu, M., & Doré, J. J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042513 · Cited by 151 · cited 1×
“, 2021) and indirectly by promoting SMAD activity (Hough et al., 2012; Shi et al., 2020).”
BackgroundNotch Signaling Mediates Secondary Senescence
Teo, Y. V., Rattanavirotkul, N., Olova, N., Salzano, A., Quintanilla, A., Tarrats, N., Kiourtis, C., Müller, M., Green, A. R., Adams, P. D., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.104 · Cited by 149 · cited 1×
“Mostly through the SASP, senescent cells also help coordinate the response of nearby and distant damaged cells and even trigger secondary senescence (Acosta et al., 2013; Parry et al., 2018; Teo et al., 2019).”
BackgroundRegulation of cellular senescence by extracellular matrix during chronic fibrotic diseases
Blokland, K. E. C., Pouwels, S. D., Schuliga, M. J., Knight, D. A., & Burgess, J. K. (2020) · Clinical Science · doi:10.1042/cs20190893 · Cited by 148 · cited 2×
“increasingly recognized as being important for the overall senescence program, as highlighted in recent reports on the relevance of integrins for senescent cells (Blokland et al., 2020; Borghesan and O’Loghlen, 2017; Rapisarda et al., 2017; Jung et al., 2019; Shin et al., 2020; Anerillas et al., 2022b).”
BackgroundGui, T., Sun, Y., Shimokado, A., & Muragaki, Y. (2012) · Journal of Signal Transduction · doi:10.1155/2012/289243 · Cited by 146
Structural and mechanistic insights into mechanoactivation of focal adhesion kinase
Bauer, M. S., Baumann, F., Daday, C., Redondo, P. N., Durner, E., Jobst, M. A., Milles, L. F., Mercadante, D., Pippig, D. A., Gaub, H. E., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820567116 · Cited by 142 · cited 1×
“For example, the enlarged and flattened morphology of senescent cells, better appreciated in culture, likely reflects focal adhesion processes (Bauer et al., 2019) in addition to hyperactivated mTOR signaling, as previously proposed (Demidenko and Blagosklonny, 2009).”
BackgroundCrosstalk between p53 and TGF- β Signalling
Elston, R., & Inman, G. J. (2012) · Journal of Signal Transduction · doi:10.1155/2012/294097 · Cited by 125 · cited 1×
“TGF-β and p53 induce p21 expression (Dupont et al., 2004; Elston and Inman, 2012; Baar et al., 2017), and may jointly support the implementation of an EMT-like program in senescent cells (Cordenonsi et al.”
BackgroundRinon, A., Molchadsky, A., Nathan, E., Yovel, G., Rotter, V., Sarig, R., & Tzahor, E. (2011) · Development · doi:10.1242/dev.053645 · Cited by 122
Cancer stem cells and signaling pathways in radioresistance
Chang, L., Graham, P., Hao, J., Ni, J., Deng, J., Bucci, J. A., Malouf, D. J., Gillatt, D. A., & Li, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6760 · Cited by 122 · cited 3×
“Downstream of membrane receptors, many signaling pathways related to both EMT and senescence are activated along with the MAPKs; these signaling modules include WNT-β-Catenin, NOTCH, SMADs, AKT-mTOR, and STATs (Acosta et al., 2013; Munoz-Espin et al., 2013; Herranz et al., 2015; Laberge et al., 2015; Hoare et al., 201…”
BackgroundGanesan, R., Mallets, E. R., & Gómez-Cambronero, J. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.006 · Cited by 113 · cited 1×
“Nonetheless, the EMT is a complex, cell type-dependent program that relies on multiple transcription factors, sometimes shared and sometimes exclusive to each cell context (Zavadil et al., 2004; Leroy and Mostov, 2007; Dhasarathy et al., 2011; Ganesan et al., 2016; Dongre and Weinberg, 2019; Sundararajan et al., 2019;…”
BackgroundLiu, L., Sun, Q., Davis, F. M., Mao, J., Zhao, H., & Ma, D. (2022) · Burns & Trauma · doi:10.1093/burnst/tkac011 · Cited by 112
Chiu, L.-Y., Hsin, I., Yang, T.-Y., Sung, W.-W., Chi, J.-Y., Chang, J. T., Ko, J., & Sheu, G. (2016) · Oncogene · doi:10.1038/onc.2016.195 · Cited by 110 · cited 4×
“The evidence that ERK1/2 activate EMT core transcription factors like SNAIL, SLUG, TWIST, ZEB1, and ZEB2 (Weiss et al., 2012; Strippoli et al., 2015; Chiu et al., 2017; Sinh et al., 2017; Yuan et al., 2022) is mainly obtained from cancer cell studies.”
BackgroundInfluentialOverstreet, J. M., Samarakoon, R., Meldrum, K. K., & Higgins, P. J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.017 · Cited by 108 · cited 1×
“, 2017), and may jointly support the implementation of an EMT-like program in senescent cells (Cordenonsi et al., 2003; Teodoro et al., 2006; Sasai et al., 2008; Overstreet et al., 2014; Kawarada et al., 2016).”
BackgroundYu, W., Imoto, I., Inoue, J., Onda, M., Emi, M., & Inazawa, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209899 · Cited by 108 · cited 1×
“, by inducing phosphatases like the dual-specificity phosphatases, DUSPs), but the specific MAPKs inhibited vary depending on the cell type, the stimulus, and the phosphatases expressed (Lu et al., 2007; Yu et al., 2007; Lokareddy et al., 2013; Fischer, 2017).”
BackgroundEpithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths
Smit, M. A., & Peeper, D. S. (2010) · Aging · doi:10.18632/aging.100209 · Cited by 108 · cited 1×
“It was proposed that proteins like TWIST and ZEB1 from the EMT program opposed senescence by inhibiting p53 (Thiery et al., 2009; Smit and Peeper, 2010).”
BackgroundRitschka, B., Knauer-Meyer, T., Gonçalves, D. S., Mas, A., Plassat, J.-L., Durik, M., Jacobs, H., Pedone, E., Di Vicino, U., Cosma, M. P., et al. (2020) · Genes & Development · doi:10.1101/gad.332643.119 · Cited by 105 · cited 2×
“The fact that senescent cells produce pro-EMT proteins suggests that they may contribute to fibrosis in detrimental scenarios (Schafer et al., 2017; Levi et al., 2020; Ritschka et al., 2020; Anerillas et al., 2022a).”
BackgroundNOTCH-mediated non-cell autonomous regulation of chromatin structure during senescence
Parry, A. J., Hoare, M., Bihary, D., Hänsel-Hertsch, R., Smith, S., Tomimatsu, K., Mannion, E., Smith, A., D’Santos, P., Russell, I. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04283-9 · Cited by 102 · cited 1×
“Mostly through the SASP, senescent cells also help coordinate the response of nearby and distant damaged cells and even trigger secondary senescence (Acosta et al., 2013; Parry et al., 2018; Teo et al., 2019).”
BackgroundDemidenko, Z. N., & Blagosklonny, M. V. (2009) · Aging · doi:10.18632/aging.100115 · Cited by 98 · cited 1×
“, 2019) in addition to hyperactivated mTOR signaling, as previously proposed (Demidenko and Blagosklonny, 2009).”
BackgroundIntegrin-mediated adhesions in regulation of cellular senescence
Shin, E., Park, J., You, S.-T., Lee, C., Won, S.-Y., Park, J.-J., Kim, H.-B., Shim, J., Soung, N., Lee, O.-J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay3909 · Cited by 92 · cited 2×
“, 2022b), and integrin signaling is important for promoting cellular senescence (Borghesan and O’Loghlen, 2017; Rapisarda et al., 2017; Jung et al., 2019; Shin et al., 2020).”
BackgroundStrippoli, R., Loureiro, J., Moreno, V., Benedicto, I., Pérez Lozano, M. L., Barreiro, O., Pellinen, T., Minguet, S., Foronda, M., Osteso, M. T., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404127 · Cited by 91 · cited 4×
“The evidence that ERK1/2 activate EMT core transcription factors like SNAIL, SLUG, TWIST, ZEB1, and ZEB2 (Weiss et al., 2012; Strippoli et al., 2015; Chiu et al., 2017; Sinh et al., 2017; Yuan et al., 2022) is mainly obtained from cancer cell studies.”
BackgroundInfluentialTGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
Kawarada, Y., Inoue, Y., Kawasaki, F., Fukuura, K., Sato, K., Tanaka, T., Itoh, Y., & Hayashi, H. (2016) · Scientific Reports · doi:10.1038/srep35483 · Cited by 89 · cited 1×
“, 2017), and may jointly support the implementation of an EMT-like program in senescent cells (Cordenonsi et al., 2003; Teodoro et al., 2006; Sasai et al., 2008; Overstreet et al., 2014; Kawarada et al., 2016).”
BackgroundThe role of cellular senescence in tissue repair and regeneration
Antelo-Iglesias, L., Picallos-Rabina, P., Estévez‐Souto, V., Silva‐Álvarez, S. D., & Collado, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111528 · Cited by 86 · cited 1×
“This secretory trait, known as the SASP (senescence-associated secretory phenotype), has been proposed to be a core function of senescent cells, as it includes messengers and coordinators of the damage response within tissues like proinflammatory cytokines, growth factors, angiogenic factors, and matrix metalloproteas…”
BackgroundConvergence of p53 and TGF-beta signaling networks
Dupont, S., Zacchigna, L., Adorno, M., Soligo, S., Volpin, D., Piccolo, S., & Cordenonsi, M. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.008 · Cited by 82 · cited 1×
“TGF-β and p53 induce p21 expression (Dupont et al., 2004; Elston and Inman, 2012; Baar et al., 2017), and may jointly support the implementation of an EMT-like program in senescent cells (Cordenonsi et al.”
BackgroundSingh, S. T., Howell, D., Trivedi, N., Kessler, K., Ong, T., Rosmaninho, P., Raposo, A. A. S. F., Robinson, G. W., Roussel, M. F., Castro, D. S., et al. (2016) · eLife · doi:10.7554/elife.12717 · Cited by 82
PRMT1-p53 Pathway Controls Epicardial EMT and Invasion
Jackson‐Weaver, O., Ungvijanpunya, N., Yuan, Y., Qian, J., Gou, Y., Wu, J., Shen, H. M., Chen, Y., Li, M., Richard, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107739 · Cited by 78 · cited 1×
“Finally, p53 opposes EMT by inhibiting SLUG in vivo (Rinon et al., 2011; Jackson-Weaver et al., 2020) and TWIST1 and ZEB1 in cancer cells (Chang et al.”
BackgroundCellular Senescence in Lung Fibrosis
Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137012 · Cited by 76
The Tumor Suppressor p53 Abrogates Smad-dependent Collagen Gene Induction in Mesenchymal Cells
Ghosh, A. K., Bhattacharyya, S., & Varga, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403477200 · Cited by 74 · cited 1×
“On the other hand, excess p53 activity can inhibit the function of the TGF-β-SMAD2/3 axis by increasing production of COL1A2, a pro-fibrotic collagen (Ghosh et al., 2004), or by tilting the balance between SMAD2/3 and SMAD1/5/9 (Guo and Wang, 2009; Zou et al.”
BackgroundEarly SRC activation skews cell fate from apoptosis to senescence
Anerillas, C., Herman, A. B., Rossi, M., Munk, R., Lehrmann, E., Martindale, J. L., Cui, C.-Y., Abdelmohsen, K., De, S., & Gorospe, M. (2022) · Science Advances · doi:10.1126/sciadv.abm0756 · Cited by 71
Self-citationSinh, N. D., Endo, K., Miyazawa, K., & Saitoh, M. (2017) · Cancer Science · doi:10.1111/cas.13214 · Cited by 65 · cited 4×
“The evidence that ERK1/2 activate EMT core transcription factors like SNAIL, SLUG, TWIST, ZEB1, and ZEB2 (Weiss et al., 2012; Strippoli et al., 2015; Chiu et al., 2017; Sinh et al., 2017; Yuan et al., 2022) is mainly obtained from cancer cell studies.”
BackgroundInfluentialJia, S., Wang, W., Hu, Z., Shan, C., Wang, L., Wu, B., Yang, Z., Yang, X., & Lei, D. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.10.008 · Cited by 64 · cited 1×
“, 2022a), and was proposed to enhance the EMT program (Jia et al., 2015; Cherubini et al., 2017; Tinaburri et al., 2021).”
BackgroundGupta, S., & Maitra, A. (2016) · Cell · doi:10.1016/j.cell.2016.02.024 · Cited by 63
Werden, S. J., Sphyris, N., Sarkar, T. R., Paranjape, A. N., LaBaff, A. M., Taube, J. H., Hollier, B. G., Ramirez‐Peña, E., Soundararajan, R., den Hollander, P., et al. (2016) · Oncogene · doi:10.1038/onc.2016.203 · Cited by 63 · cited 4×
“Finally, p53 opposes EMT by inhibiting SLUG in vivo (Rinon et al., 2011; Jackson-Weaver et al., 2020) and TWIST1 and ZEB1 in cancer cells (Chang et al., 2011; Yang-Hartwich et al., 2019; Semenov et al., 2022).”
BackgroundInfluentialTGFβ2-induced senescence during early inner ear development
Gibaja, A., Aburto, M. R., Pulido, S., Collado, M., Hurlé, J. M., Varela‐Nieto, I., & Magariños, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-42040-0 · Cited by 61 · cited 1×
“Downstream of membrane receptors, many signaling pathways related to both EMT and senescence are activated along with the MAPKs; these signaling modules include WNT-β-Catenin, NOTCH, SMADs, AKT-mTOR, and STATs (Acosta et al., 2013; Munoz-Espin et al., 2013; Herranz et al., 2015; Laberge et al., 2015; Hoare et al., 201…”
BackgroundWang, Y., Su, B., & Xia, Z. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605503200 · Cited by 59 · cited 1×
“Remarkably, ERK5 participates in an extracellular signaling program involving BDNF to sustain neuronal viability and promote neurogenesis (Liu et al., 2003; Wang et al., 2006), the latter linked to EMT (Singh et al.”
BackgroundMarchetti, A., Colletti, M., Cozzolino, A. M., Steindler, C., Lunadei, M., Mancone, C., & Tripodi, M. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.08.002 · Cited by 58 · cited 1×
“In cancer cells, ERK5 either promotes or inhibits SNAIL function (Marchetti et al., 2008; Xu et al., 2021), although ERK5 activation usually promotes EMT by increasing the function of SLUG, ZEB1, and ZEB2 (Arnoux et al.”
BackgroundWip1 phosphatase: between p53 and MAPK kinases pathways
Goloudina, A. R., Kochetkova, E. Y., Pospelova, T. V., & Demidov, O. N. (2016) · Oncotarget · doi:10.18632/oncotarget.7325 · Cited by 58 · cited 1×
“, 2011), although WIP1 suppresses other MAPKs in different cell types (Goloudina et al., 2016).”
BackgroundLiu, C., Lin, J.-H., Hsu, T.-W., Hsu, J., Chang, J.-W., Su, K., Hsu, H., & Hung, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11208 · Cited by 56 · cited 1×
“Furthermore, many of the molecules secreted by senescent cells, including cytokines, growth factors, and ECM proteins, are known EMT triggers (Krtolica et al., 2001; Parrinello et al., 2005; Yilmaz and Christofori, 2009; Coppe et al., 2010; Acosta et al., 2013; Lamouille et al., 2014; Hoare et al., 2016; Cherubini et…”
BackgroundHyperactivated JNK Is a Therapeutic Target in pVHL-Deficient Renal Cell Carcinoma
An, J., Liu, H., Magyar, C. E., Guo, Y., Veena, M. S., Srivatsan, E. S., Huang, J., & Rettig, M. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2362 · Cited by 55 · cited 1×
“For instance, JNK activates the transcription factor AP-1, which can promote the expression of genes associated with EMT, such as SNAIL, SLUG, and TWISTs in both cancer and normal cells (Li et al., 2010; An et al., 2013; Feldker et al., 2020).”
Backgroundp53–Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT
Yang‐Hartwich, Y., Tedja, R., Roberts, C. M., Goodner-Bingham, J., Cardenas, C., Gurea, M., Sumi, N. J., Alvero, A. B., Glackin, C. A., & Mor, G. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0238 · Cited by 53 · cited 1×
“, 2020) and TWIST1 and ZEB1 in cancer cells (Chang et al., 2011; Yang-Hartwich et al., 2019; Semenov et al., 2022).”
BackgroundSNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
Sundararajan, V., Tan, M., Tan, T. Z., Ye, J., Thiery, J. P., & Huang, R. Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-44826-8 · Cited by 53 · cited 1×
“Nonetheless, the EMT is a complex, cell type-dependent program that relies on multiple transcription factors, sometimes shared and sometimes exclusive to each cell context (Zavadil et al., 2004; Leroy and Mostov, 2007; Dhasarathy et al., 2011; Ganesan et al., 2016; Dongre and Weinberg, 2019; Sundararajan et al., 2019;…”
BackgroundJung, S. H., Lee, M., Park, H. A., Lee, H., Kang, D., Hwang, H. J., Park, C., Yu, D., Jung, Y. R., Mi-Na, H. O. N. G., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0114-7 · Cited by 50 · cited 2×
“, 2022b), and integrin signaling is important for promoting cellular senescence (Borghesan and O’Loghlen, 2017; Rapisarda et al., 2017; Jung et al., 2019; Shin et al., 2020).”
BackgroundSTAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence
Bryson, B. L., Junk, D. J., Cipriano, R., & Jackson, M. W. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1259037 · Cited by 48 · cited 1×
“Downstream of membrane receptors, many signaling pathways related to both EMT and senescence are activated along with the MAPKs; these signaling modules include WNT-β-Catenin, NOTCH, SMADs, AKT-mTOR, and STATs (Acosta et al., 2013; Munoz-Espin et al., 2013; Herranz et al., 2015; Laberge et al., 2015; Hoare et al., 201…”
BackgroundWitte, D. P., Otterbein, H., Förster, M., Giehl, K., Zeiser, R., Lehnert, H., & Ungefroren, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-15170-6 · Cited by 48 · cited 12×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundInfluentialOpposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition
Semenov, O., Daks, A. A., Fedorova, O., Shuvalov, O. Y., & Barlev, N. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.928399 · Cited by 48 · cited 1×
“, 2020) and TWIST1 and ZEB1 in cancer cells (Chang et al., 2011; Yang-Hartwich et al., 2019; Semenov et al., 2022).”
BackgroundRyu, K.-J., Park, S.-M., Park, S.-H., Kim, I.-K., Han, H., Kim, H.-J., Kim, S.-H., Hong, K.-S., Kim, H., Kim, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0049 · Cited by 47 · cited 4×
“Finally, p53 opposes EMT by inhibiting SLUG in vivo (Rinon et al., 2011; Jackson-Weaver et al., 2020) and TWIST1 and ZEB1 in cancer cells (Chang et al., 2011; Yang-Hartwich et al., 2019; Semenov et al., 2022).”
BackgroundInfluentialEctodermal Factor Restricts Mesoderm Differentiation by Inhibiting p53
Sasai, N., Yakura, R., Kamiya, D., Nakazawa, Y., & Sasai, Y. (2008) · Cell · doi:10.1016/j.cell.2008.03.035 · Cited by 46 · cited 1×
“, 2017), and may jointly support the implementation of an EMT-like program in senescent cells (Cordenonsi et al., 2003; Teodoro et al., 2006; Sasai et al., 2008; Overstreet et al., 2014; Kawarada et al., 2016).”
BackgroundAntoon, J. W., Martin, E. C., Lai, R., Salvo, V. A., Tang, Y., Nitzchke, A. M., Elliott, S. G., Nam, S. Y., Xiong, W., Rhodes, L. V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069291 · Cited by 43
UV irradiation induces Snail expression by AP-1 dependent mechanism in human skin keratinocytes
Li, Y., Liu, Y., Xu, Y., Voorhees, J. J., & Fisher, G. J. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.08.003 · Cited by 43 · cited 1×
“For instance, JNK activates the transcription factor AP-1, which can promote the expression of genes associated with EMT, such as SNAIL, SLUG, and TWISTs in both cancer and normal cells (Li et al., 2010; An et al., 2013; Feldker et al., 2020).”
BackgroundA new Twist in kidney fibrosis
Ovadya, Y., & Krizhanovsky, V. (2015) · Nature Medicine · doi:10.1038/nm.3938 · Cited by 42 · cited 2×
“A strong connection is emerging between cellular senescence and EMT, two processes associated with fibrosis (Ovadya and Krizhanovsky, 2015; Schafer et al., 2017; Di Gregorio et al., 2020; Levi et al., 2020; Ritschka et al., 2020; Anerillas et al., 2022a).”
BackgroundAntoon, J. W., Nitzchke, A. M., Martin, E. C., Rhodes, L. V., Nam, S., Wadsworth, S. A., Salvo, V. A., Elliott, S. G., Collins‐Burow, B. M., Nephew, K. P., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1814 · Cited by 42
Ohkuro, M., Kim, J., Kuboi, Y., Hayashi, Y., Mizukami, H., Kobayashi-Kuramochi, H., Muramoto, K., Shirato, M., Michikawa-Tanaka, F., Moriya, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04420-4 · Cited by 41 · cited 1×
“Importantly, the activity of ERK1/2 increases via ECM receptors and ECM ligands (Sheng et al., 2017; Ohkuro et al., 2018; Olea-Flores et al., 2019), and thus ERK1/2 activity could represent a key signaling node to adjust cell outcome to ECM status (Anerillas et al.”
BackgroundJNK‐dependent gene regulatory circuitry governs mesenchymal fate
Sahu, S. K., Garding, A., Tiwari, N., Thakurela, S., Toedling, J., Gebhard, S., Ortega, F., Schmarowski, N., Berninger, B., Nitsch, R., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490693 · Cited by 40 · cited 1×
“Finally, JNKs have been proposed to control the progression of the EMT program downstream of TGF-β actions (Lamouille et al., 2014; Sahu et al., 2015).”
BackgroundXu, Q., Zhang, J., Telfer, B. A., Zhang, H., Ali, N., Chen, F., Risa-Ebrí, B., Pearson, A. J., Zhang, W., Finegan, K. G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01798-2 · Cited by 39
Huang, M., Wang, Y., Zhu, L., Cai, Q., Li, H., & Yang, H. (2015) · Environmental Toxicology · doi:10.1002/tox.22146 · Cited by 38 · cited 1×
“Most of our current knowledge linking MAPKs and the EMT is from cancer studies (Gui et al., 2012; Huang et al., 2016; Bhatt et al., 2021; Liu et al., 2022), generally describes MAPKs as promoting the FIGURE 1 Overview of possible senescence-related pro-EMT pathways.”
BackgroundRoles of Integrins in Gastrointestinal Cancer Metastasis
Hou, S., Wang, J., Li, W., Hao, X., & Hang, Q. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.708779 · Cited by 38 · cited 2×
“Furthermore, many of the molecules secreted by senescent cells, including cytokines, growth factors, and ECM proteins, are known EMT triggers (Krtolica et al., 2001; Parrinello et al., 2005; Yilmaz and Christofori, 2009; Coppe et al., 2010; Acosta et al., 2013; Lamouille et al., 2014; Hoare et al., 2016; Cherubini et…”
BackgroundMolecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling
Bhatt, A. B., Patel, S., Matossian, M. D., Uçar, D. A., Miele, L., Burow, M. E., Flaherty, P. T., & Cavanaugh, J. E. (2021) · Biomolecules · doi:10.3390/biom11020183 · Cited by 37 · cited 2×
“ERK5 has also been associated with the EMT program downstream of mitogenic factors, TGF-β, and integrins (Bhatt et al., 2021).”
BackgroundCherubini, E., Mariotta, S., Scozzi, D., Mancini, R., Osman, G. A., D’Ascanio, M., Bruno, P., Cardillo, G., & Rícci, A. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1298-1 · Cited by 35 · cited 2×
“Furthermore, many of the molecules secreted by senescent cells, including cytokines, growth factors, and ECM proteins, are known EMT triggers (Krtolica et al., 2001; Parrinello et al., 2005; Yilmaz and Christofori, 2009; Coppe et al., 2010; Acosta et al., 2013; Lamouille et al., 2014; Hoare et al., 2016; Cherubini et…”
BackgroundA BDNF-TrkB autocrine loop enhances senescent cell viability
Anerillas, C., Herman, A. B., Munk, R., Garrido, A., Lam, K.-W. G., Payea, M. J., Rossi, M., Tsitsipatis, D., Martindale, J. L., Piao, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33709-8 · Cited by 35
Self-citationIntegrins in senescence and aging
Borghesan, M., & O’Loghlen, A. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1316573 · Cited by 32 · cited 2×
“, 2022b), and integrin signaling is important for promoting cellular senescence (Borghesan and O’Loghlen, 2017; Rapisarda et al., 2017; Jung et al., 2019; Shin et al., 2020).”
BackgroundAtomic Structure of Dual-Specificity Phosphatase 26, a Novel p53 Phosphatase
Lokareddy, R. K., Bhardwaj, A., & Cingolani, G. (2013) · Biochemistry · doi:10.1021/bi301476m · Cited by 27
Tinaburri, L., Valente, C., Teson, M., Minafò, Y. A., Cordisco, S., Guerra, L., & Dellambra, E. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.08.019 · Cited by 20 · cited 1×
“, 2022a), and was proposed to enhance the EMT program (Jia et al., 2015; Cherubini et al., 2017; Tinaburri et al., 2021).”
BackgroundYuan, X., Xiao, H., Hu, Q., Shen, G., & Qin, X. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100276 · Cited by 14 · cited 4×
“The evidence that ERK1/2 activate EMT core transcription factors like SNAIL, SLUG, TWIST, ZEB1, and ZEB2 (Weiss et al., 2012; Strippoli et al., 2015; Chiu et al., 2017; Sinh et al., 2017; Yuan et al., 2022) is mainly obtained from cancer cell studies.”
BackgroundInfluential
Cited by
The YAP-TEAD complex promotes senescent cell survival by lowering endoplasmic reticulum stress
Anerillas, C., Mazan-Mamczarz, K., Herman, A. B., Munk, R., Lam, K.-W. G., Calvo-Rubio, M., Garrido, A., Tsitsipatis, D., Martindale, J. L., Altés, G., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00480-4 · Cited by 76
Self-citationSharma, R., & Bala, E. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100579 · Cited by 21
Dietary restriction promote sperm remodeling in aged roosters based on transcriptome analysis
Liang, W., He, Y., Zhu, T., Zhang, B., Liu, S., Guo, H.-S., Liu, P., Liu, H., Li, D., Kang, X., et al. (2024) · BMC Genomics · doi:10.1186/s12864-024-10544-3 · Cited by 17
“In mammals, MAPK can be translated as “mitogen-activated protein kinase” Regulating cell proliferation, differentiation, movement, and survival is one of the important pathways affecting testis development and spermatogenesis [43].”
BackgroundAnerillas, C., Altés, G., Gresova, K., Tsitsipatis, D., Mazan-Mamczarz, K., Banarjee, R., Cunningham, A. S. G., Salamini-Montemurri, M., Yang, J.-H., Munk, R., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.05.017 · Cited by 11
Self-citationSenescence and Stress Signaling Pathways in Corneal Cells After Nitrogen Mustard Injury
Anwar, K. N., Soleimani, M., Ashraf, M. J., Moghtader, A., Koganti, R., Ghalibafan, S., Baharnoori, S. M., Arabpour, Z., Cheraqpour, K., Sebhat, A. M., et al. (2024) · Cells · doi:10.3390/cells13232021 · Cited by 6
Metadata
- Authors
- Anerillas, C., Altés, G., & Gorospe, M.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Anerillas, Carlos
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2023-03-16
- Volume
- 11
- Pages
- 1083401-1083401
- ISSN
- 2296-634X (ISSN-L)
- PMC
- PMC10060890
- OpenAlex
- W4327606035
- Cited by
- 13
- References
- 141
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 1
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- MAPK signaling, cellular senescence, epithelial-mesenchymal transition, DNA damage response, apoptosis, cell survival, tissue function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.